Call for Late Breaking Abstracts
>> hot off the bench and straight from the bedside <<
The EAACI is now accepting late-breaking abstracts for the upcoming Annual Meeting 2006 in Vienna. Late-breaking abstract submission provides an opportunity for individuals to submit important research advance. A brief statement justifying why the abstract is important or late breaking is a submission requirement.
Late breaking Abstracts
What are late breaking abstracts?
Abstracts that describe important current research advances that have not been submitted previously. Please note: Late breaking abstracts are not a second chance to submit a study for the second time in hope to be selected for an oral presentation. Individuals listed as first authors of standard abstracts are not prohibited from submitting late-breaking abstracts, provided that the late breaking abstract describes a study different from the previously submitted study. Individuals submitting a late breaking abstract must indicate authors and co-authors that have already submitted a standard abstract.
Selection of abstracts will be based on scientific quality and novelty of research either in basic or clinical science. In order to be considered for presentation at the EAACI Annual Meeting 2006, late-breaking abstracts must be submitted via this website. The submission deadline for late breaking abstracts is April 12th 2006 at 12.00 CET. For more information, contact Congrex at: firstname.lastname@example.org
Only abstracts not published elsewhere or submitted for presentation at another national and/or international meeting will be considered for presentation.
ABSTRACT SUBMISSION DEADLINE: 12 APRIL 2006 at 12.00 CET
Registration and payment
The presenting author must register for the congress and pay the registration when submitting the abstract, otherwise it will not be reviewed. If the abstract is not accepted the registration fee is refundable.
Carefully read the guidelines in this announcement before submitting your abstract. Abstracts can only be submitted electronically through this web page.
Acknowledgement of receipt of your submission will be returned to your e-mail address immediately upon submission. If you do not receive the e-mail, your submission was not completed and your abstract needs to be re-submitted.
Invited speakers are not supposed to submit abstracts to the lectures they are invited for.
Abstracts must be written in English and the presentations must be in English. Use maximum 2500 characters (approximately 350 words) including blank steps for the abstract text. The abstract title and the author(s) or names of institutions are not to be included in the 2500 characters.
In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study, the method used, the result observed, and the conclusions based upon the results. It is inadequate to state "The results will be discussed" or "The data will be presented". You may subtitle the paragraphs in bold format in the following order: Background, Method, Results, and Conclusion.
The abstract title and body text should only include pharmacopeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required at the first place a drug is mentioned. References, credits or the authors' academic degrees or grant support are not to be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text.
Accepted abstracts selected by expert reviewers will be presented in oral and poster sessions. Poster presenters will be asked to be present by their poster during poster session. Authors should indicate in the space provided the preferred method of presentation. It is the author's responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Please note that each year a number of abstracts are rejected because they contain no data or the English is unacceptable.
Changes to abstracts can only be accepted until the submission deadline by using the Personal Page. You can access your Personal Page by using your password included in the e-mail received upon submission.
Notification of acceptance
Notification of acceptance/rejection will be e-mailed end April (contact Congrex if you have not received your notification e-mail by the beginning of May). The corresponding author will receive all correspondence concerning the abstract. The corresponding author is responsible for informing all authors of the status of the abstract.
Publication of abstracts
Accepted abstracts will be published in the Abstract Book in Vienna. Accepted abstracts will also be published on a CD-ROM and/or the Internet.
For support please contact: email@example.com